SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-027073
Filing Date
2022-05-04
Accepted
2022-05-04 16:15:01
Documents
2
Period of Report
2022-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1610
2 POA DOCUMENT poa.txt EX-24 3524
  Complete submission text file 0001209191-22-027073.txt   6567
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTEIR THERAPEUTICS, INC. 128 SPRING STREET, BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address
Veness Adam M (Reporting) CIK: 0001778623 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40499 | Film No.: 22891682